Publications
5677 Results
- Journal / Conference
- ASPO Annual Meeting (March 12-14, 2023, San Diego, CA)
- Year
- 2023
- Research Committee(s)
- Palliative Care
- Study Number(s)
- S1316
Ability to Eat among Cancer Patients Treated for Malignant Bowel Obstruction: A Secondary Analysis within SWOG S1316
- Journal / Conference
- St. Gallen International Breast Cancer Conference (March 15-18, 2023; St. Gallen, Switzerland), e-poster
- Year
- 2023
- Research Committee(s)
- Breast
[CTP] TROPION-Breast03: Datopotamab deruxtecan (Dato-DXd) with or without durvalumab vs investigator's choice of therapy (ICT) for triple-negative breast cancer (TNBC) with residual disease following neoadjuvant therapy
- Journal / Conference
- Haematologica. Apr 6. doi: 10.3324/haematol.2023.282733. Online ahead of print
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID37021537
- PMC
- PMC Journal - In Process
- Study Number(s)
- S0106, S0112, SWOG-9031, SWOG-9333
Examining the impact of age on the prognostic value of ELN-2017 and ELN-2022 AML risk stratifications: A SWOG report
- Journal / Conference
- Blood Advances Jun 30;bloodadvances.2023010223. doi: 10.1182/bloodadvances.2023010223. Online ahead of print
- Year
- 2023
- Research Committee(s)
- Lymphoma
- PMID
- PMID37389844
- Study Number(s)
- CTSU/9177
Prognostic Factors for Adult Burkitt Lymphoma Patients Treated with Dose-Adjusted EPOCH-R
- Journal / Conference
- CLINICAL CANCER RESEARCH
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID: 37531248
- PMC
- PMC10690084
- Study Number(s)
- MYELOMATCH
The new NCI precision medicine Trials
- Journal / Conference
- Blood Advances
- Year
- 2023
- Research Committee(s)
- Leukemia
- PMID
- PMID37267439
- PMC
- PMC10562769
- Study Number(s)
- S0106
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, ECOG analysis
- Journal / Conference
- JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY Jul 18:S0022-5223(23)00612-8
- Year
- 2023
- Research Committee(s)
- Lung
- PMID
- PMID37473998
- PMC
- In Process at NIHMS NIHMS1919951
Lobectomy, segmentectomy or wedge resection for peripheral clinical T1aN0 non-small cell lung cancer: a post-hoc analysis of CALGB 140503 (Alliance)
- Journal / Conference
- Journal of Clinical Oncology
- Year
- 2023
- Research Committee(s)
- Lymphoma
- PMID
- PMID36495588
- PMC
- PMC10082254
- Study Number(s)
- S0816
The Advanced-Stage Hodgkin Lymphoma International Prognostic Index: Development and Validation of a Clinical Prediction Model From the HoLISTIC Consortium
- Journal / Conference
- Nature Medicine Sep;29(9):2278-2285
- Year
- 2023
- Research Committee(s)
- Melanoma
- PMID
- PMID37592104
- PMC
- PMCID10708907
- Study Number(s)
- S1616
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial
- Journal / Conference
- JAMA Oncology Oct 1;9(10):1371-1379
- Year
- 2023
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID37590003
- PMC
- PMC10436183